Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Antitumor activity of new chemical agents in mammary adenocarcinoma models

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: GIOLITO, María Virginia (Instituto de Genetica Experimental, Oncology, Rosario, Argentina)
  • Co-author(s): María Virginia Giolito: Oncology, Instituto de Genetica Experimental, Rosario, Argentina
    Patricia Cornier: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
    Carina Delpiccolo: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
    Antonela Del Giúdice : Oncology, Instituto de Genetica Experimental, Rosario, Argentina
    Dora B. Boggian: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
    Mauricio Menacho Marquez: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina
    Leandro Mainetti: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina
    O. Graciela Scharovsky: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina;, cic-unr, Rosario, Argentina
    Ernesto Mata: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
    Viviana Rozados: Oncology, Instituto de Genetica Experimental, Rosario, Argentina
    María José Rico: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina
  • Abstract:

    Backgrounds

    New antitumor agents are needed due to the toxicity of the antitumor drugs, the development of resistance and the scarcity of effective therapies. 

    Aims

    To evaluate antitumor activity of novel compounds and their mechanisms of action. 

    Methods

    In vitro a)We tested the antitumor activity (WST1) of 44 novel compounds: aminoacyl/peptidyl

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses